Indication

Excretion

1 clinical trial

1 product

Clinical trial

A Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-Simufilam Following a Single Oral Dose in Healthy Male Subjects

Status: Completed, Estimated PCD: 2024-03-27

Product